1st Quarter - Report

ENDGAME STRATEGIES, LLC for MCGOVERN & ASSOCIATES

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Issues relating to drug innovation, drug repurposing, intellectual property protections for innovators; and the Hatch-Waxman Act. The Independent Innovator and Repurposing Act, S. 2150; HR 4287

LobbyistCovered position, as disclosed
STEVEN DUFFIELD Judiciary Analyst/Counse, Sen Repub Policy Com

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4287 (113th), S. 2150 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.